Immunosuppressant and anti-inflammatory combination

This page covers all Immunosuppressant and anti-inflammatory combination drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Purine metabolism (azathioprine); NF-κB pathway (mesalazine).

Targets

Purine metabolism (azathioprine); NF-κB pathway (mesalazine)

Phase 3 pipeline (1)

• Azathioprine OR Mesalazine · Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives · Gastroenterology / Immunology
  This is a combination therapy study comparing azathioprine (an immunosuppressant) and mesalazine (an anti-inflammatory) for inflammatory bowel disease.

Patent intelligence

• immunosuppressant and anti inflammatory combination patent landscape — aggregated cliff calendar, attackable patents, originator estates